HUM|Analyst Targets
HUM|Company Info
HUM|Insider Trading
HUM|Fundamentals
HUM|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $-1.00 | - | - |
| Q2'26 | $7.29 | $7.61 | +4.3% |
| Q1'26 | $10.16 | $10.31 | +1.5% |
| Q4'25 | $10.57 | $-3.96 | -137.5% |
| Q3'25 | $2.83 | $3.24 | +14.6% |
| Q2'25 | $5.87 | $6.27 | +6.9% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $41.3B | - | - |
| Q2'26 | $41.0B | $40.9B | -0.3% |
| Q1'26 | $39.4B | $39.6B | +0.7% |
| Q4'25 | $35.5B | $32.6B | -8.1% |
| Q3'25 | - | $32.6B | - |
| Q2'25 | - | $32.4B | - |
HUM|Monthly Returns
Market Data
HUM Stock Snapshot
- Market cap
- 46.71B
- P/E ratio
- 36.5
- Day range
- $396.04 – $408.04
- News sentiment
- 42/100 · Neutral
- Analyst target
- $423.74 (+4.8%)
- Consensus
- Hold · 34 analysts
Humana Inc. screens well technically, with price sitting near its 52-week high. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.
Reverse DCF
What growth is priced into HUM?
At today's price, Humana Inc. needs to grow free cash flow about 56.2% a year for the next 10 years to justify its valuation at a 7.86% cost of capital. Over its actual history it has compounded free cash flow at 3.3% a year, so the market is asking for 52.9 percentage points above its own delivered rate. On that basis HUM looks priced above what its own growth record supports.
- Implied FCF growth
- 56.2%
- Historical FCF CAGR
- 3.3%
- Growth gap
- +52.9 pts
- Verdict
- RICH
- Discount rate (WACC)
- 7.86%
- Beta
- 0.71
Behaviour On Record
What HUM's own history says about today's numbers
- Realized volatility (21d)
- 31.7% 68th pct
- Below its peak
- -28.4%
- vs 200-day average
- +37.6%
- Up days (1y)
- 53%
Humana Inc. is currently running 31.7% annualised volatility over the last 21 sessions. Measured against HUM's own 13 years of daily returns rather than a market-wide average, that is the 68th percentile — a little above its own norm, against a typical reading of 25.2%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
HUM is trading -28.4% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -22.5%, and the deepest was -49.9% in 2024. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +37.6% from its 200-day moving average. Against every other day in its history, that gap ranks at the 97th percentile — a wider gap than this stock usually carries. Over the past year HUM closed higher on 53% of sessions, and it is currently 2 sessions into a rising streak.
On October specifically: over 13 years of records, HUM finished the month higher 7 of 13 times, with a median return of +4.2% and an average of +4.3%. Its strongest month historically has been May at +6.5% on average, its weakest January at -3.8%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: HUM has opened more than 2% away from the prior close in 101 of 3,268 sessions (3.1% of the time), with the largest gaps running +8.9% and -11.8%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, HUM moved an average of 1.8% in the session after earnings, closing higher 2 of those 3 times, with a median move of +1.8% and a largest of -1.8%.
All figures computed from 3,269 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against HUM's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of HUM's sector?
Humana Inc. sits in the Health Care sector, currently ranked 8th of 12 GICS sectors by relative-strength rotation score (lagging).
- Sector rank
- #8 of 12
- Sector state
- Lagging
- Sector rotation score
- 0
Analyst Rating Changes
Are analysts turning bullish or bearish on HUM?
Barclays most recently upgraded Humana Inc. to Overweight on Sep 25, 2026 with a price target of $515 (from $407). Over the last 90 days, coverage has run 4 upgrades against 1 downgrade, a net bullish lean.
- Latest action
- Barclays — Overweight
- 90-day upgrades
- 4
- 90-day downgrades
- 1
- Net rating momentum
- +3
HUM Competitive Positioning
Held by These ETFs
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | ▲ Buy | 10,417,803 | 9.02% | $4.14B | 2026-08-07 |
| Vanguard Group Inc | ▲ Buy | 14,261,860 | 12.34% | $3.65B | 2026-01-29 |
| JPMorgan Chase & Co | ▼ Sell | 4,087,837 | 3.54% | $1.59B | 2026-08-12 |
| Geode Capital Management, LLC | ▲ Buy | 3,369,757 | 2.92% | $1.34B | 2026-08-12 |
| Goldman Sachs Group Inc | ▲ Buy | 3,144,289 | 2.72% | $1.25B | 2026-08-14 |
| FMR LLC (Fidelity) | ▲ Buy | 2,913,763 | 2.52% | $1.16B | 2026-08-13 |
| Susquehanna International Group, LLP | ▼ Sell | 2,250,770 | 1.95% | $894.05M | 2026-08-14 |
| Citadel Advisors LLC | • Hold | 2,146,522 | 1.86% | $852.64M | 2026-09-02 |
| Norges Bank | ▼ Sell | 1,748,414 | 1.51% | $694.51M | 2026-08-12 |
| Invesco Ltd. | ▼ Sell | 1,478,788 | 1.28% | $587.40M | 2026-08-14 |
| Morgan Stanley | ▼ Sell | 1,349,066 | 1.17% | $535.88M | 2026-08-13 |
| Capital Research Global Investors | ▲ Buy | 1,116,990 | 0.97% | $443.46M | 2026-08-12 |
| Northern Trust Corp | ▼ Sell | 1,115,198 | 0.97% | $442.98M | 2026-08-13 |
| Capital World Investors | ▲ Buy | 1,022,425 | 0.88% | $406.12M | 2026-08-12 |
| Wellington Management Group LLP | ▲ Buy | 765,355 | 0.66% | $304.01M | 2026-08-14 |
| Bank of America Corp | ▼ Sell | 703,615 | 0.61% | $279.49M | 2026-08-14 |
| Marshall Wace, LLP | ▲ Buy | 550,178 | 0.48% | $218.54M | 2026-08-13 |
| Millennium Management LLC | ▲ Buy | 467,398 | 0.40% | $185.66M | 2026-08-14 |
| Artisan Partners Limited Partnership | ▼ Sell | 684,778 | 0.59% | $175.39M | 2026-02-17 |
| D. E. Shaw & Co., Inc. | ▼ Sell | 358,843 | 0.31% | $142.54M | 2026-08-14 |
| Squarepoint Ops LLC | ▼ Sell | 274,499 | 0.24% | $109.04M | 2026-08-14 |
| Neuberger Berman Group LLC | ▲ Buy | 267,369 | 0.23% | $106.20M | 2026-08-13 |
| Glenview Capital Management, LLC | ▼ Sell | 254,216 | 0.22% | $100.98M | 2026-08-14 |
| Davis Selected Advisers | • Hold | 385,539 | 0.33% | $100.31M | 2025-12-29 |
| Gotham Asset Management, LLC | ▲ Buy | 224,860 | 0.19% | $89.32M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Julia Letlow | House | LA05 | ▼ Sell | $1K - $15K | 2026-02-10 | 2026-03-12 |
| Gilbert Cisneros | House | CA31 | ▼ Sell | $1K - $15K | 2025-11-12 | 2025-12-15 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-31 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-30 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-10-30 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-09-25 | 2025-10-22 |
| Julia Letlow | House | LA05 | ▲ Buy | $1K - $15K | 2025-08-08 | 2026-01-13 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2025-08-05 | 2025-09-12 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-06-24 | 2025-08-13 |
| Gilbert Cisneros | House | CA31 | ▼ Sell | $1K - $15K | 2025-05-30 | 2025-06-06 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-05-15 | 2025-06-09 |
| Gilbert Cisneros | House | CA31 | ▼ Sell | $1K - $15K | 2025-04-29 | 2025-05-06 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2025-02-26 | 2025-03-06 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-02-25 | 2025-03-27 |